Publikationen (21) Publikationen, an denen Forscher/innen teilgenommen haben

2010

  1. Adjuvant docetaxel for high-risk, node-negative breast cancer

    New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210

  2. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: A prospective analysis of axillary or distant recurrence

    Annals of Surgical Oncology, Vol. 17, Núm. 3, pp. 772-777

  3. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer

    Oncogene, Vol. 29, Núm. 45, pp. 6071-6083

  4. Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients

    Lung Cancer, Vol. 68, Núm. 3, pp. 491-497

  5. Construyendo un aprendizaje cooperativo e integrador. Experiencia de innovación docente en el marco del EEES

    Metas de enfermería, Vol. 13, Núm. 1, pp. 50-55

  6. Current controversies in the management of breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286

  7. Current perspectives of treatment of ductal carcinoma in situ

    Cancer Treatment Reviews, Vol. 36, Núm. 7, pp. 507-517

  8. Cáncer de ovario. Enfermedad platino sensible

    Revisiones en Cancer, Vol. 24, Núm. 6, pp. 245-252

  9. Evaluation of immunoassays as an alternative for the rapid determination of pesticides in wine and grape samples

    Journal of AOAC International, Vol. 93, Núm. 1, pp. 2-11

  10. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

  11. Hidromorfona: Una alternativa en el tratamiento del dolor

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 3, pp. 153-161

  12. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)

    Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803

  13. Intervención farmacéutica en gestante. Derivación al médico para modificar la posición del feto

    Farmacéuticos comunitarios, Vol. 2, Núm. 2, pp. 74-75

  14. Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157

  15. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer

    Annals of the New York Academy of Sciences, Vol. 1210, Núm. 1, pp. 86-92

  16. Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer

    Clinical Lung Cancer, Vol. 11, Núm. 2, pp. 105-113

  17. Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 6, pp. 289-292

  18. Recent advances in cancer therapy: An overview

    Current Pharmaceutical Design, Vol. 16, Núm. 1, pp. 3-10

  19. SEOM clinical guidelines for the treatment of metastatic breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 719-723

  20. Supportive care for patients with early breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 1, pp. 32-42